| Literature DB >> 29546662 |
R Cameron Coates1, Benjamin P Bowen1,2, Ernst Oberortner1, Linda Thomashow3,4, Michalis Hadjithomas1, Zhiying Zhao1, Jing Ke1, Leslie Silva1, Katherine Louie1, Gaoyan Wang1, David Robinson1, Angela Tarver1, Matthew Hamilton1, Andrea Lubbe2, Meghan Feltcher5, Jeffery L Dangl5,6,7,8,9, Amrita Pati1, David Weller3,4, Trent R Northen1,2, Jan-Fang Cheng1,2, Nigel J Mouncey1, Samuel Deutsch1,2,10, Yasuo Yoshikuni11,12,13.
Abstract
Increasing availability of new genomes and putative biosynthetic gene clusters (BGCs) has extended the opportunity to access novel chemical diversity for agriculture, medicine, environmental and industrial purposes. However, functional characterization of BGCs through heterologous expression is limited because expression may require complex regulatory mechanisms, specific folding or activation. We developed an integrated workflow for BGC characterization that integrates pathway identification, modular design, DNA synthesis, assembly and characterization. This workflow was applied to characterize multiple phenazine-modifying enzymes. Phenazine pathways are useful for this workflow because all phenazines are derived from a core scaffold for modification by diverse modifying enzymes (PhzM, PhzS, PhzH, and PhzO) that produce characterized compounds. We expressed refactored synthetic modules of previously uncharacterized phenazine BGCs heterologously in Escherichia coli and were able to identify metabolic intermediates they produced, including a previously unidentified metabolite. These results demonstrate how this approach can accelerate functional characterization of BGCs.Entities:
Keywords: Biosynthesis; Pathway; Pathway design; Phenazine; Refactored; Synthetic biology
Mesh:
Substances:
Year: 2018 PMID: 29546662 DOI: 10.1007/s10295-018-2025-5
Source DB: PubMed Journal: J Ind Microbiol Biotechnol ISSN: 1367-5435 Impact factor: 3.346